Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus–negative Head and Neck Squamous Cell Carcinoma
2019
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Acute Biological Effects of Simulating the Whole-Body Radiation Dose Distribution from a Solar Particle Event Using a Porcine Model
2011 StandoutNobel
How chemokines organize the tumour microenvironment
2023
Cardiac Toxicity Following Thoracic Radiation
2005
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells
2011 StandoutNobel
Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
2015
The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)
2006 Standout
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Extra and Intracellular Synthesis of Nickel Oxide Nanoparticles Mediated by Dead Fungal Biomass
2015
Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation
2016
The biology and management of non-small cell lung cancer
2018 StandoutNature
A point dose method forin vivorange verification in proton therapy
2008
Gene therapy for thyroid cancer
2004
Common Musculoskeletal Tumors of Childhood and Adolescence
2012
Postoperative Proton Radiotherapy for Localized and Locoregional Breast Cancer: Potential for Clinically Relevant Improvements?
2009
Epigenetic control of gene expression: Potential implications for cancer treatment
2017
The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells
2006
Range uncertainties in proton therapy and the role of Monte Carlo simulations
2012 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Proton beam therapy and localised prostate cancer: current status and controversies
2013
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Breathing adapted radiotherapy for breast cancer: Comparison of free breathing gating with the breath-hold technique
2005
Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patients
2010
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
2018 Standout
Cancer and Radiation Therapy: Current Advances and Future Directions
2012 Standout
Late effects from hadron therapy
2004
Radiotherapy-induced thyroid disorders
2004
The molecular landscape of head and neck cancer
2018 Standout
Radiotherapy: what can be achieved by technical improvements in dose delivery?
2005
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis
2017
Intensity modulated radiation therapy using laser-accelerated protons: a Monte Carlo dosimetric study
2003
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
Particle Radiation Therapy Using Proton and Heavier Ion Beams
2007
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
The oncolytic virusdl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma
2015
Optics in the relativistic regime
2006 StandoutNobel
Works of Laura Cella being referenced
Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors
2002
Complication Probability Models for Radiation-Induced Heart Valvular Dysfunction: Do Heart-Lung Interactions Play a Role?
2014
ONYX-015 Enhances Radiation-Induced Death of Human Anaplastic Thyroid Carcinoma Cells
2003
Multivariate Normal Tissue Complication Probability Modeling of Heart Valve Dysfunction in Hodgkin Lymphoma Survivors
2013
Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes
2003
Modeling the risk of radiation-induced lung fibrosis: Irradiated heart tissue is as important as irradiated lung
2015
Ionizing radiation enhances dl922–947-mediated cell death of anaplastic thyroid carcinoma cells
2013
Potential role of intensity modulated proton beams in prostate cancer radiotherapy
2001
Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin’s lymphoma
2011
A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients
2013
Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications
2014